Popular Articles

StemCells, Inc. To Present Phase I Clinical Trial Results At The 12th International Congress On NCL
StemCells, Inc. (NASDAQ:STEM) announced plans to present data from its Phase I clinical trial of its proprietary HuCNS-SC® product candidate (purified human neural stem cells) at the 12th International Congress on Neuronal Ceroid Lipofuscinoses (NCL) being held June 3 - 6, 2009 in Hamburg, Germany. Stephen Huhn, MD, FACS, FAAP, vice president and head of the Company"s CNS program, is scheduled to present the data on Saturday, June 6.

Japan's Cases Of New H1N1 Flu Surge Over Weekend
The number of confirmed cases of new A/H1N1 swine flu in Japan surged over the weekend, when health officials reported earlier today,
News of the day
FDA Approves SBi's S.T.A.R.(R) Total Ankle Replacement System
Small Bone Innovations, Inc. (SBi), a leading provider of innovation, products, technology and education for the small bone & joint segment of the orthopedics industry, announced that the U.S. Food and Drug Administration (FDA) has approved SBi"s Scandinavian Total Ankle Replacement (S.T.A.R.®) system to treat U.S. patients. S.T.A.R. has received pre-market approval (PMA) to replace a painful arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid arthritis.
Diagnostics

Also In Global Health News: Text Messages To Fight Polio; TB At Pakistani Relief Camps; ARV Supply In Uganda

UNICEF Using SMS Text Messages To Fight Polio In Zambia UNICEF has partnered with African companies to send SMS text messages to millions of Zambian parents as part of a new initiative to prevent polio, Computerworld reports. Millions of cell phone subscribers will be sent messages about activities aimed at fighting the disease. The campaign is taking place in 28 Zambian districts that border Angola, Namibia and the Democratic Republic of Congo (Malakata, 7/24). Authorities Concerned About New TB Cases At Pakistani Relief Camps Tuberculosis control authorities are concerned about 340 new cases of TB that have been detected among displaced people from the war-affected areas in Pakistan, Dawn.com reports. "Among the total cases detected, 944 were those who had already been infected before coming to the camps. An additional number of 340 patients became infected after their arrival at relief camps," writes the Web site (7/25). New Vision Examines ARV Supply In Uganda The New Vision examines recent reports out of Uganda that some HIV/AIDS clinics are either closing or scaling back the number of patients they see because of a lack of antiretrovirals (ARVs). The article features comments from various HIV/AIDS experts, including PEPFAR country coordinator Michael Strong, who said, "We expect that PEPFAR funding for Uganda will continue at its current level of around $280m annually through 2013. But this will still leave a gap between national treatment needs and the funds available. Uganda needs to identify other res to fill this gap" (Basudde, 7/24). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):